<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-18T05:09:44Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/ijcem.000063">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/ijcem.000063</identifier>
									<datestamp>2025-03-28</datestamp>
									<setSpec>PTZ.IJCEM:VOL11</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Free Triiodothyronine Toxicosis in Adolescent Monozygotic Twin Brothers
										</dc:title><dc:creator>Mikołaj Kuncewicz</dc:creator><dc:creator> Dorota Szydlarska</dc:creator><dc:creator> Marta Ciechomska</dc:creator><dc:creator>Katarzyna Życińska</dc:creator><dc:description>&lt;p&gt;Free triiodothyronine toxicosis is a rare condition, expressed by isolated triiodothyronine concentration elevation, resulting in an overt hypermetabolic state. Diagnosis and treatment are particularly important&amp;nbsp; in young populations during puberty, with intensive intellectual and physical development. We present a case of monozygotic adolescent male twins, with cardiovascular symptoms, along with anxiety, hypersensitivity and insomnia. The free triiodothyronine toxicosis in the absence of anti-thyroid antibodies. Successful treatment with symptom relief and laboratory results normalization was achieved after 8 weeks of anti-thyroid medication with beta-blocker addition. The described condition may be an early stage of developing disease, so further follow-up is obligatory. Because the case presents an atypical population for the disorder, with brothers additionally being monozygotic twins, genetic factors should be taken into consideration in the event of disease progression.&lt;/p&gt;</dc:description>
										<dc:publisher>International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications</dc:publisher>
										<dc:date>2025-03-28</dc:date>
										<dc:type>Case Report</dc:type>
										<dc:identifier>https://doi.org/10.17352/ijcem.000063</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Mikołaj Kuncewicz et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
